Tangli Xiao

1.5k total citations
29 papers, 1.1k citations indexed

About

Tangli Xiao is a scholar working on Nephrology, Molecular Biology and Genetics. According to data from OpenAlex, Tangli Xiao has authored 29 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Nephrology, 8 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Tangli Xiao's work include Chronic Kidney Disease and Diabetes (15 papers), Parathyroid Disorders and Treatments (12 papers) and Renal Diseases and Glomerulopathies (5 papers). Tangli Xiao is often cited by papers focused on Chronic Kidney Disease and Diabetes (15 papers), Parathyroid Disorders and Treatments (12 papers) and Renal Diseases and Glomerulopathies (5 papers). Tangli Xiao collaborates with scholars based in China and United States. Tangli Xiao's co-authors include Jinghong Zhao, Ke Yang, Ting He, Xu Guan, Xinli Xu, Jingbo Zhang, Ling Nie, Yunjian Huang, Junping Wang and Jiachuan Xiong and has published in prestigious journals such as SHILAP Revista de lepidopterología, The FASEB Journal and Kidney International.

In The Last Decade

Tangli Xiao

28 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tangli Xiao China 15 534 378 144 131 120 29 1.1k
Yunjian Huang China 20 505 0.9× 320 0.8× 120 0.8× 151 1.2× 179 1.5× 31 1.1k
Ernesto Martín‐Núñez Spain 18 548 1.0× 310 0.8× 173 1.2× 74 0.6× 180 1.5× 51 1.2k
Chun‐Tao Lei China 16 310 0.6× 353 0.9× 83 0.6× 75 0.6× 86 0.7× 26 908
Ryohei Kaseda Japan 17 472 0.9× 275 0.7× 51 0.4× 111 0.8× 213 1.8× 39 1.1k
Mitsuo Tanimoto Japan 20 396 0.7× 222 0.6× 69 0.5× 180 1.4× 143 1.2× 45 1.1k
Seon Ho Ahn South Korea 7 446 0.8× 546 1.4× 77 0.5× 156 1.2× 177 1.5× 11 1.2k
Orestes Foresto‐Neto Brazil 16 429 0.8× 492 1.3× 79 0.5× 68 0.5× 136 1.1× 24 1.1k
Xiaofen Xiong China 16 285 0.5× 592 1.6× 72 0.5× 147 1.1× 123 1.0× 22 1.2k
Yung‐Chien Hsu Taiwan 18 425 0.8× 560 1.5× 76 0.5× 70 0.5× 182 1.5× 41 1.2k
Hajime Nagasu Japan 19 463 0.9× 668 1.8× 103 0.7× 149 1.1× 288 2.4× 54 1.6k

Countries citing papers authored by Tangli Xiao

Since Specialization
Citations

This map shows the geographic impact of Tangli Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tangli Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tangli Xiao more than expected).

Fields of papers citing papers by Tangli Xiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tangli Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tangli Xiao. The network helps show where Tangli Xiao may publish in the future.

Co-authorship network of co-authors of Tangli Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Tangli Xiao. A scholar is included among the top collaborators of Tangli Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tangli Xiao. Tangli Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yin, Liangyu, Tangli Xiao, Jun Zhang, et al.. (2025). Functional Performance Decline Outperforms Sarcopenia and Its Components in Predicting New-Onset Chronic Kidney Disease: A Nationwide Multicenter Study. Kidney Medicine. 7(6). 101005–101005. 1 indexed citations
2.
Zhang, Bo, Yaqin Wang, Tangli Xiao, et al.. (2025). Acetylation-regulated DUSP1 deficiency contributes to renal fibrosis progression. Theranostics. 15(9). 3781–3796. 3 indexed citations
3.
Wang, Yaqin, Jiachuan Xiong, Tangli Xiao, et al.. (2025). Single-cell analysis of proximal tubular cells with different DNA content reveals functional heterogeneity in the acute kidney injury to chronic kidney disease transition. Kidney International. 108(1). 90–104. 1 indexed citations
4.
Xiao, Tangli, et al.. (2024). Genetic diagnosis of Alport syndrome in 16 Chinese families. Molecular Genetics & Genomic Medicine. 12(3). e2406–e2406. 1 indexed citations
5.
Wang, Yating, Yu Shi, Tangli Xiao, et al.. (2024). A Klotho-Based Machine Learning Model for Prediction of both Kidney and Cardiovascular Outcomes in Chronic Kidney Disease. SHILAP Revista de lepidopterología. 10(3). 200–212. 1 indexed citations
6.
7.
Li, Xiong, Ting He, Chi Liu, et al.. (2023). IL-37 Ameliorates Renal Fibrosis by Restoring CPT1A-Mediated Fatty Acid Oxidation in Diabetic Kidney Disease. SHILAP Revista de lepidopterología. 9(2). 104–117. 8 indexed citations
8.
Li, Haiyang, Yinghui Huang, Ting He, et al.. (2022). Potential Role of the Renal Arterial Resistance Index in the Differential Diagnosis of Diabetic Kidney Disease. Frontiers in Endocrinology. 12. 731187–731187. 10 indexed citations
9.
Ling, Nie, et al.. (2022). A Pathogenic Variant of PBX1 Identified by Whole Exome Sequencing in a Chinese CAKUTHED Case. ˜The œNephron journals/Nephron journals. 147(5). 311–316. 1 indexed citations
10.
Li, Yan, Yong Liu, Yinghui Huang, et al.. (2020). IRF‐1 promotes renal fibrosis by downregulation of Klotho. The FASEB Journal. 34(3). 4415–4429. 19 indexed citations
11.
Huang, Yinghui, Jie Zhou, Shaobo Wang, et al.. (2020). Indoxyl sulfate induces intestinal barrier injury through IRF1-DRP1 axis-mediated mitophagy impairment. Theranostics. 10(16). 7384–7400. 87 indexed citations
12.
Li, Yan, Yong Liu, Kailong Wang, et al.. (2020). Klotho is regulated by transcription factor Sp1 in renal tubular epithelial cells. BMC Molecular and Cell Biology. 21(1). 45–45. 15 indexed citations
13.
Yang, Ke, Jiangxin Yang, Xianjin Bi, et al.. (2020). Serum Klotho, Cardiovascular Events, and Mortality in Nondiabetic Chronic Kidney Disease. Cardiorenal Medicine. 10(3). 175–187. 23 indexed citations
14.
Jiang, Wei, Tangli Xiao, Wenhao Han, et al.. (2019). Klotho inhibits PKCα/p66SHC-mediated podocyte injury in diabetic nephropathy. Molecular and Cellular Endocrinology. 494. 110490–110490. 43 indexed citations
15.
He, Ting, Jiachuan Xiong, Yinghui Huang, et al.. (2019). Klotho restrain RIG-1/NF-κB signaling activation and monocyte inflammatory factor release under uremic condition. Life Sciences. 231. 116570–116570. 19 indexed citations
16.
Liu, Yong, Xianjin Bi, Jiachuan Xiong, et al.. (2019). MicroRNA-34a Promotes Renal Fibrosis by Downregulation of Klotho in Tubular Epithelial Cells. Molecular Therapy. 27(5). 1051–1065. 127 indexed citations
17.
He, Ting, Jiachuan Xiong, Ling Nie, et al.. (2016). Resveratrol inhibits renal interstitial fibrosis in diabetic nephropathy by regulating AMPK/NOX4/ROS pathway. Journal of Molecular Medicine. 94(12). 1359–1371. 115 indexed citations
18.
Yang, Ke, Xinli Xu, Ling Nie, et al.. (2015). Indoxyl sulfate induces oxidative stress and hypertrophy in cardiomyocytes by inhibiting the AMPK/UCP2 signaling pathway. Toxicology Letters. 234(2). 110–119. 64 indexed citations
19.
Xiao, Tangli, Xu Guan, Ling Nie, et al.. (2014). Rapamycin promotes podocyte autophagy and ameliorates renal injury in diabetic mice. Molecular and Cellular Biochemistry. 394(1-2). 145–154. 75 indexed citations
20.
Yang, Ke, Ling Nie, Yunjian Huang, et al.. (2012). Amelioration of uremic toxin indoxyl sulfate-induced endothelial cell dysfunction by Klotho protein. Toxicology Letters. 215(2). 77–83. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yunjian Huang Breakdown of academic impact, for papers by Ernesto Martín‐Núñez Breakdown of academic impact, for papers by Chun‐Tao Lei Breakdown of academic impact, for papers by Ryohei Kaseda Breakdown of academic impact, for papers by Mitsuo Tanimoto Breakdown of academic impact, for papers by Seon Ho Ahn Breakdown of academic impact, for papers by Orestes Foresto‐Neto Breakdown of academic impact, for papers by Xiaofen Xiong Breakdown of academic impact, for papers by Yung‐Chien Hsu Breakdown of academic impact, for papers by Hajime Nagasu
Rankless by CCL
2026